Previous studies have shown that PLK4 inhibition suppresses cell division and enhances immune surveillance in aggressive hepatocellular carcinoma, further supporting its role in regulating the cell cycle and DNA content45. The gene discussed is PLK4; the disease is hepatocellular carcinoma.